[ad_1]
An Irish study found that a drug used to treat breast cancer by thousands of women increases the risk of developing uterine cancer.
Researchers found that taking tamoxifen for 10 years instead of the standard would increase the risk of endometrial cancer by 1.5% to 3.5%.
Previous research suggests that tamoxifen inhibits estrogen from stimulating growth Breast Cancer
Although the drug inhibits the action of estrogen in breast tissue, it works as a hormone in the uterus, which increases the risk of cancer of its lining.
Researchers from the St. Vincent Hospital Group in Dublin analyzed four studies examining the link between endometrial cancer in women who took tamoxifen for 10 years.
The results published in the British Journal of Surgery also indicated that the drug was taken for 5 years. Increases the risk by 2%.
According to the American Cancer Society, amoxifene uterine cancer accounts for about one in every 500 women.
Endometrial cancer can reduce the risk of cancer in the womb. endometrial by maintaining a healthy weight and eating healthy, exercising regularly and controlling the level of sugar if necessary. (19659002) Source: Daily Mail
Dima Hanna
[ad_2]
Source link
